Nano Letters is a monthly peer-reviewed scientific journal published by the American Chemical Society. It was established in January 2001. The two editors-in-chief are A. Paul Alivisatos (University of California, Berkeley) and Charles M. Lieber (Harvard University). The 2010 impact factor for Nano Letters is 12.219, according to the Journal Citation Reports. The focus of the journal is rapid dissemination of selected elements regarding fundamental, original research reports on all topics related to the theory and practice of nanoscience and nanotechnology and their subdisciplines. Physical, chemical, and biological phenomena related to nanoscience and nanotechnology are part of this focus. Furthermore nanoscale materials science is also included, focusing on processes and applications of structures at this size. Subject coverage encompasses the following: Materials that are synthesized and processed by physical, chemical, and biological methods. The classes of these materials are organic, inorganic, and hybrid. Furthermore, these processes are subjects of modeling and simulation. Specifically these process range from synthesis to assembly, along with relevant interactions. Also of
Scientists at the UK's Bangor and Oxford universities have achieved a world first: using spider-silk as a superlens to increase the microscope's potential.
In the drive to miniaturize electronics, solenoids have become way too big, say Rice University scientists who discovered the essential component can be scaled down to nano-size with macro-scale performance.
Rice University researchers have demonstrated an efficient new way to capture the energy from sunlight and convert it into clean, renewable energy by splitting water molecules.
Most of the world's electricity-producing power plants—whether powered by coal, natural gas, or nuclear fission—make electricity by generating steam that turns a turbine. That steam then is condensed back to water, and ...
The global rise in antibiotic resistance is a growing threat to public health, damaging our ability to fight deadly infections such as tuberculosis.